Published in Epigenomics on December 01, 2009
Beyond TGFβ: roles of other TGFβ superfamily members in cancer. Nat Rev Cancer (2013) 1.67
Tumor cell vasculogenic mimicry: from controversy to therapeutic promise. Am J Pathol (2012) 1.58
Accumulation of multipotent progenitors with a basal differentiation bias during aging of human mammary epithelia. Cancer Res (2012) 1.20
A model of cancer stem cells derived from mouse induced pluripotent stem cells. PLoS One (2012) 1.17
Embryonic signaling in melanoma: potential for diagnosis and therapy. Lab Invest (2011) 1.07
Cancer hallmarks in induced pluripotent cells: new insights. J Cell Physiol (2010) 0.93
Nodal expression and detection in cancer: experience and challenges. Cancer Res (2012) 0.92
Tumor cell vascular mimicry: Novel targeting opportunity in melanoma. Pharmacol Ther (2016) 0.86
Targeting nodal in conjunction with dacarbazine induces synergistic anticancer effects in metastatic melanoma. Mol Cancer Res (2015) 0.86
Melanoma tumor cell heterogeneity: a molecular approach to study subpopulations expressing the embryonic morphogen nodal. Semin Oncol (2014) 0.85
Effects of a novel Nodal-targeting monoclonal antibody in melanoma. Oncotarget (2015) 0.85
Characterization of nodal/TGF-lefty signaling pathway gene variants for possible roles in congenital heart diseases. PLoS One (2014) 0.83
The bed and the bugs: interactions between the tumor microenvironment and cancer stem cells. Semin Cancer Biol (2012) 0.83
Characterization of SMAD3 Gene Variants for Possible Roles in Ventricular Septal Defects and Other Congenital Heart Diseases. PLoS One (2015) 0.82
Cancer stem cells converted from pluripotent stem cells and the cancerous niche. J Stem Cells Regen Med (2014) 0.82
Epigenomics in cancer management. Cancer Manag Res (2010) 0.81
New Anti-Nodal Monoclonal Antibodies Targeting the Nodal Pre-Helix Loop Involved in Cripto-1 Binding. Int J Mol Sci (2015) 0.81
Bioengineering embryonic stem cell microenvironments for the study of breast cancer. Int J Mol Sci (2011) 0.81
Plasticity underlies tumor progression: role of Nodal signaling. Cancer Metastasis Rev (2016) 0.81
Notch signal integration in the vasculature during remodeling. Vascul Pharmacol (2014) 0.80
Divergence(s) in nodal signaling between aggressive melanoma and embryonic stem cells. Int J Cancer (2014) 0.79
Breast Cancer beyond the Age of Mutation. Gerontology (2015) 0.78
Mining gene expression signature for the detection of pre-malignant melanocytes and early melanomas with risk for metastasis. PLoS One (2012) 0.77
Lefty Glycoproteins in Human Embryonic Stem Cells: Extracellular Delivery Route and Posttranslational Modification in Differentiation. Stem Cells Dev (2016) 0.76
The Epigenomics of Embryonic Pathway Signaling in Colorectal Cancer. Front Pharmacol (2017) 0.76
Prokineticin 2 (PROK2) is an important factor for angiogenesis in colorectal cancer. Oncotarget (2015) 0.75
Cancer stem cells of differentiated B-cell malignancies: models and consequences. Cancers (Basel) (2011) 0.75
Characterization of Transcriptional Repressor Gene MSX1 Variations for Possible Associations with Congenital Heart Diseases. PLoS One (2015) 0.75
Microfluidic Biopsy Trapping Device for the Real-Time Monitoring of Tumor Microenvironment. PLoS One (2017) 0.75
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31
Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res (1998) 106.16
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res (1988) 32.89
The epigenomics of cancer. Cell (2007) 30.91
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature (2007) 21.53
A microRNA component of the p53 tumour suppressor network. Nature (2007) 19.25
Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell (2008) 16.38
Endogenous human microRNAs that suppress breast cancer metastasis. Nature (2008) 14.37
miRNAs, cancer, and stem cell division. Cell (2005) 12.15
Retracted A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell (2009) 10.51
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol (2008) 7.27
MicroRNA expression and function in cancer. Trends Mol Med (2006) 7.02
Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res (2007) 5.09
Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nat Med (2006) 4.54
Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight. Adv Exp Med Biol (2008) 4.12
Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol Cell Biol (2008) 4.07
Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci U S A (2009) 4.00
Reprogramming metastatic tumour cells with embryonic microenvironments. Nat Rev Cancer (2007) 3.17
Nodal signaling in vertebrate development. Annu Rev Cell Dev Biol (2003) 3.09
Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA (2008) 3.03
The miR-430/427/302 family controls mesendodermal fate specification via species-specific target selection. Dev Cell (2009) 3.01
Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci U S A (2008) 2.51
Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line. Int J Cancer (1991) 2.26
Notch signaling regulates left-right asymmetry determination by inducing Nodal expression. Genes Dev (2003) 1.76
Non-coding RNAs: lost in translation? Gene (2006) 1.58
MicroRNA expression in melanocytic nevi: the usefulness of formalin-fixed, paraffin-embedded material for miRNA microarray profiling. J Invest Dermatol (2008) 1.54
Molecular therapy in the microRNA era. Pharmacogenomics J (2006) 1.52
Structural conservation of Notch receptors and ligands. Semin Cell Dev Biol (1998) 1.46
Treatments for metastatic melanoma: synthesis of evidence from randomized trials. Cancer Treat Rev (2007) 1.37
A three-dimensional model to study the epigenetic effects induced by the microenvironment of human embryonic stem cells. Stem Cells (2005) 1.26
Cancer-associated genomic regions (CAGRs) and noncoding RNAs: bioinformatics and therapeutic implications. Mamm Genome (2008) 1.23
Modulation of potassium channel function confers a hyperproliferative invasive phenotype on embryonic stem cells. Proc Natl Acad Sci U S A (2008) 1.22
Nodal as a biomarker for melanoma progression and a new therapeutic target for clinical intervention. Expert Rev Dermatol (2009) 1.19
Targeting Nodal in malignant melanoma cells. Expert Opin Ther Targets (2007) 1.05
The commonality of plasticity underlying multipotent tumor cells and embryonic stem cells. J Cell Biochem (2007) 0.97
SATR-1 hypomethylation is a common and early event in breast cancer. Cancer Genet Cytogenet (2006) 0.96
Genome sequence of Aedes aegypti, a major arbovirus vector. Science (2007) 9.19
Integrative annotation of 21,037 human genes validated by full-length cDNA clones. PLoS Biol (2004) 7.17
Epidermal growth factor receptor (EGFR) signaling in cancer. Gene (2005) 6.04
Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nat Med (2006) 4.54
Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat Rev Cancer (2003) 3.93
Reprogramming metastatic tumour cells with embryonic microenvironments. Nat Rev Cancer (2007) 3.17
A molecular role for lysyl oxidase in breast cancer invasion. Cancer Res (2002) 2.65
Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci U S A (2008) 2.51
Paradoxical roles for lysyl oxidases in cancer--a prospect. J Cell Biochem (2007) 2.30
Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells. Cancer Res (2005) 2.27
Molecular plasticity of human melanoma cells. Oncogene (2003) 2.16
Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion. Am J Pathol (2004) 2.12
The H-Invitational Database (H-InvDB), a comprehensive annotation resource for human genes and transcripts. Nucleic Acids Res (2007) 2.07
Cyanobacterial contribution to algal nuclear genomes is primarily limited to plastid functions. Curr Biol (2006) 2.03
Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications. Am J Pathol (2007) 1.99
Does heterochromatin protein 1 always follow code? Proc Natl Acad Sci U S A (2002) 1.97
Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. Cancer Res (2005) 1.95
Maspin regulates different signaling pathways for motility and adhesion in aggressive breast cancer cells. Cancer Biol Ther (2003) 1.85
Transcriptional patterns in both host and bacterium underlie a daily rhythm of anatomical and metabolic change in a beneficial symbiosis. Proc Natl Acad Sci U S A (2010) 1.82
Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas. JAMA (2009) 1.81
The fate of human malignant melanoma cells transplanted into zebrafish embryos: assessment of migration and cell division in the absence of tumor formation. Dev Dyn (2005) 1.78
Science policy. The NIH budget in the "postdoubling" era. Science (2002) 1.74
The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res (2002) 1.71
Reprogramming metastatic melanoma cells to assume a neural crest cell-like phenotype in an embryonic microenvironment. Proc Natl Acad Sci U S A (2006) 1.67
Insights into a dinoflagellate genome through expressed sequence tag analysis. BMC Genomics (2005) 1.65
Tumor cell vasculogenic mimicry: from controversy to therapeutic promise. Am J Pathol (2012) 1.58
Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer. Clin Cancer Res (2002) 1.57
Reevaluating cathepsin D as a biomarker for breast cancer: serum activity levels versus histopathology. Cancer Biol Ther (2010) 1.55
Biological functions of maspin. J Cell Physiol (2006) 1.54
The presence of simian-virus 40 sequences in mesothelioma and mesothelial cells is associated with high levels of vascular endothelial growth factor. Am J Respir Cell Mol Biol (2002) 1.53
Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications. Clin Cancer Res (2012) 1.52
Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry. Cancer Res (2003) 1.50
Molecular determinants of human uveal melanoma invasion and metastasis. Clin Exp Metastasis (2002) 1.50
Regulation of the embryonic morphogen Nodal by Notch4 facilitates manifestation of the aggressive melanoma phenotype. Cancer Res (2010) 1.49
Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells. J Natl Cancer Inst (2004) 1.49
Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells. Cancer Biol Ther (2005) 1.49
Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia. Cancer Res (2005) 1.49
Identification of Differentially Expressed MicroRNAs in Osteosarcoma. Sarcoma (2011) 1.48
Mammary serine protease inhibitor (Maspin) binds directly to interferon regulatory factor 6: identification of a novel serpin partnership. J Biol Chem (2005) 1.44
Differential regulation of EphA2 in normal and malignant cells. Am J Pathol (2003) 1.43
Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration. J Cell Biochem (2008) 1.41
p53 null mutations are associated with a telomerase negative phenotype in ovarian carcinoma. Cancer Biol Ther (2002) 1.41
VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry. Cancer Biol Ther (2006) 1.41
p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas. Mol Cancer Ther (2004) 1.40
Transendothelial function of human metastatic melanoma cells: role of the microenvironment in cell-fate determination. Cancer Res (2002) 1.36
ErbB/EGF signaling and EMT in mammary development and breast cancer. J Mammary Gland Biol Neoplasia (2010) 1.36
Life cycle transcriptome of the malaria mosquito Anopheles gambiae and comparison with the fruitfly Drosophila melanogaster. Proc Natl Acad Sci U S A (2007) 1.36
Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry. Cancer Res (2003) 1.35
Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells. Prostate (2011) 1.34
An insight into the sialome of Glossina morsitans morsitans. BMC Genomics (2010) 1.34
Expression of multiple molecular phenotypes by aggressive melanoma tumor cells: role in vasculogenic mimicry. Crit Rev Oncol Hematol (2002) 1.32
Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry. Prostate (2002) 1.32
Effects of colonization, luminescence, and autoinducer on host transcription during development of the squid-vibrio association. Proc Natl Acad Sci U S A (2008) 1.32
A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src. Cancer Res (2003) 1.32
Development and cancer: at the crossroads of Nodal and Notch signaling. Cancer Res (2009) 1.30
Cripto-1: an oncofetal gene with many faces. Curr Top Dev Biol (2005) 1.26
A three-dimensional model to study the epigenetic effects induced by the microenvironment of human embryonic stem cells. Stem Cells (2005) 1.26
Genome-wide quantitative assessment of variation in DNA methylation patterns. Nucleic Acids Res (2011) 1.23
High-throughput sequence-based epigenomic analysis of Alu repeats in human cerebellum. Nucleic Acids Res (2009) 1.23
Interferon regulatory factor 6 promotes cell cycle arrest and is regulated by the proteasome in a cell cycle-dependent manner. Mol Cell Biol (2008) 1.22
Gene discovery in an invasive tephritid model pest species, the Mediterranean fruit fly, Ceratitis capitata. BMC Genomics (2008) 1.22
Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma. Oncogene (2005) 1.22
Focal adhesion kinase promotes the aggressive melanoma phenotype. Cancer Res (2005) 1.22
Maspin: molecular mechanisms and therapeutic implications. Cancer Metastasis Rev (2012) 1.21